Concepedia

A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients

Rahim M. Naimi, Karine Madsen, C. Askov-Hansen, Christopher F. Brandt, Bolette Hartmann, Jens J. Holst, Preben Bo Mortensen, Palle Bekker Jeppesen

Regulatory Peptides · 2013 · 11 citations · 19 references

DOI

Concepts

References

19

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

Patrice D. Cani, Sam Possemiers, Tom Van de Wiele et al. · Gut · 2009 · 2.5K citations · Full text

, , +17

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

Daniel J. Drucker, Porat M. Erlich, Patricia L. Brubaker · Proceedings of the National Academy of Sciences · 1996 · 875 citations

, , +16

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon

Palle Bekker Jeppesen, Bolette Hartmann, Jesper Thulesen et al. · Gastroenterology · 2001 · 531 citations · Full text

, , +15

Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans

Pascal Crenn, C. Coudray‐Lucas, F. Thuillier et al. · Gastroenterology · 2000 · 486 citations · Full text

, , +9

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

Palle Bekker Jeppesen · Gut · 2005 · 466 citations · Full text

, , +17